🇺🇸 FDA
Patent

US 7786096

Inhibition of antigen presentation with poorly catabolized polymers

granted A61KA61K31/715A61K31/721

Quick answer

US patent 7786096 (Inhibition of antigen presentation with poorly catabolized polymers) held by HALOZYME, INC. expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/715, A61K31/721, A61K39/00, A61K39/001